“Authorized” Generics Fight Moves To Capitol Hill, FTC
This article was originally published in The Pink Sheet Daily
Executive Summary
Mylan plans to meet with Hill staffers, members of Congress to lay the groundwork for legislation against “authorized” generic deals. The company is leading efforts of generic firms who are trying to persuade FTC that authorized generics do not save consumers money and result in fewer patent challenges.